Site ES34002

Barcelona 8950

1 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, Carcinoma, Transitional Cell, Clostridium Difficile-associated Diarrhea (CDAD), Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Invasive Aspergillosis, Invasive Mucormycosis, Kidney Transplantation Cytomegalovirus (CMV) Negative Recipients, Pancreatic Adenocarcinoma, Renal Pelvis Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Studies at this site

• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer — Recruiting now
• A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Completed
• A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants — Completed
• A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) — Completed
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors — Completed
• A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor — Completed
• A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer — Completed